top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Autore Moro Enrico
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (301 p.)
Soggetto topico Medicine
Soggetto non controllato mucopolysaccharidosis IIIB
quantitative proteomics
NAGLU
lysosomes
Gaucher disease
bone involvement
enzyme replacement therapy
substrate reduction therapy
Osteoimmunology
RANK/RANKL
Osteopontin
MIP-1β
mucolipidosis II
sortilin
TGF-beta
cathepsin D
Fabry disease
alpha-galactosidase A
endocytosis
lysosome
IGF2R/M6P
clathrin
chloroquine
lysosomal diseases
precision medicine
pharmacological chaperones
gene therapy
Pompe disease
lysosomal targeting
autophagy
muscle
satellite cells
rhGAA
glycogen
lysosomal α-glucosidase
GAA biomarker
Gaucher Disease
Wnt/β-catenin
Dkk1
Wnt3a
iPSC
neuronopathy
Krabbe disease
Twitcher mouse
psychosine
visual system
visual cortex
astrogliosis
mucopolysaccharidosis type I
Hurler syndrome
hematopoietic stem cell transplantations
animal models
experimental therapies
axon guidance
lysosomal storage disorders
neuronal circuit
α-galactosidase A
A4GALT
globotriaosylceramide (Gb3)
globotriaosyl-sphingosine (lysoGb3)
pharmacological chaperone therapy
exosomes
endocytic pathways
neurodegenerative disease
Parkinson disease
lysosomal storage disorder
viral vectors
newborn screening
variant interpretation
second tier test
tandem mass spectrometry
lyso-Gb3
dried blood spot
GLA gene
globotriaosylsphingosine
biomarkers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lysosomal Storage Disorders
Record Nr. UNINA-9910557545503321
Moro Enrico  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Autore Stefanachi Angela
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (416 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato EGR-1
flavonoid
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
MDA-MB-231
MMP9
TNFα
pancreatic ductal adenocarcinoma
cyclodextrin inclusion complex
phase solubility studies
preformulation studies
biphenylnicotinamide derivatives
dual inhibitor
EGFR
VEGFR2
ligand-based pharmacophore
molecular docking
molecular dynamics
leukemias
doxorubicin
inflammation
drug delivery
tumor targeting
elastin-like polypeptide
cell penetrating peptide
matrix metalloproteinase
doxorubicin resistance
photosensitizer delivery system
PAMAM dendrimer
photodynamic therapy
cytotoxicity
phototoxicity
colorectal adenocarcinoma
dicarboximides
chemical synthesis
apoptosis
kinases
anticancer
gene profiling
SAR
biomarkers
colorectal cancer
early detection examination
liquid biopsy
personalized medicine
tumor treatment
exosomes
ctDNA
CTC
cytotoxic activity
pyrazole derivatives
MTT assay
ADMET analysis
single-crystal diffraction
FTIR spectroscopy
NMR spectroscopy thermogravimetric analysis
acute myelogenous leukemia
platelets
microparticles
γδ T cells
immunotherapy
tumor resistance
combination therapy
tumor microenvironment
immune checkpoint inhibitor
neuroblastoma
molecular iodine
cyclophosphamide
xenografts
metronomic therapy
tamoxifen
CYP2D6
MCF-7
Ishikawa cells
SERM
TNBC
uterotrophic
α-mangostin
poly(amidoamine) dendrimer
targeted drug delivery
biotin targeting
glioblastoma multiforme
squamous cell carcinoma
antiparasitic therapy
diclofenac
indomethacin
oleanolic acid derivative conjugates
NF-κB
Nrf2
MAPKs
PSN-1 cells
reactive oxygen species
glioblastoma
brain tumor
extracellular vesicles
pancreatic cancer
paclitaxel
clathrin
endocytosis
sulforaphane
nicotine
metalloproteinase-9
gastric cancer
cell invasion
Arylquin 1
colon cancer
tumor progression
azelastine
oxidative stress
autophagy
mitotic catastrophe
chronic myeloid leukemia
imatinib
tyrosine kinase
ketoconazole
P-glycoprotein
drug efflux transporter
non-small-cell lung cancer
cisplatin resistance
aldehyde dehydrogenase
isothiocyanates
disulfiram
epithelial to mesenchymal transition
aminopeptidase N
acetamidophenones
Schiff bases
semicarbazones
thiosemicarbazones
inhibition of proliferation
ISBN 3-0365-5927-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639990003321
Stefanachi Angela  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui